Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Davis

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Pediatrics|April 1, 1977
Frequency and etiology of gross hematuria in a general pediatric settingJ R Ingelfinger, A E Davis, W E Grupe
Human Genetics|March 1, 1994
Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edemaJ J Bissler, V H Donaldson, A E Davis
Canadian Journal of Physiology and Pharmacology|February 1, 1974
Constancy and linearity of the metabolic clearance of adrenocorticotropin in dogsJ S Cowan, A E Davis, R A Layberry
Revista De Gastroenterologia De Mexico|September 1, 1975
Follow-up studies on liver disease associated with hepatitis B antigen carriers [proceedings]T D Bolin, A E Davis, A G Liddelow
Gut|July 1, 1977
Double-blind trial of cholestyramine in post-vagotomy diarrhoeaV M Duncombe, T D Bolin, A E Davis
The Journal of Biological Chemistry|September 27, 1996
Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251R Zahedi, K S Aulak, E Eldering, et al.
Clinical and Experimental Immunology|September 26, 2002
C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritisT R Welch, M Frenzke, D Witte, et al.
The Journal of Clinical Investigation|March 1, 1987
Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edemaM Cicardi, T Igarashi, F S Rosen, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 1, 1992
C5 deficiency in A/J mice is not associated with resistance to the development of secondary amyloidosisM Coutinho, K Zahedi, A S Whitehead, et al.
Biochemistry|November 13, 1979
Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequenceA E Davis, C Zalut, F S Rosen, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Pediatrics|April 1, 1977
Frequency and etiology of gross hematuria in a general pediatric settingJ R Ingelfinger, A E Davis, W E Grupe
Human Genetics|March 1, 1994
Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edemaJ J Bissler, V H Donaldson, A E Davis
Canadian Journal of Physiology and Pharmacology|February 1, 1974
Constancy and linearity of the metabolic clearance of adrenocorticotropin in dogsJ S Cowan, A E Davis, R A Layberry
Revista De Gastroenterologia De Mexico|September 1, 1975
Follow-up studies on liver disease associated with hepatitis B antigen carriers [proceedings]T D Bolin, A E Davis, A G Liddelow
Gut|July 1, 1977
Double-blind trial of cholestyramine in post-vagotomy diarrhoeaV M Duncombe, T D Bolin, A E Davis
The Journal of Biological Chemistry|September 27, 1996
Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251R Zahedi, K S Aulak, E Eldering, et al.
Clinical and Experimental Immunology|September 26, 2002
C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritisT R Welch, M Frenzke, D Witte, et al.
The Journal of Clinical Investigation|March 1, 1987
Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edemaM Cicardi, T Igarashi, F S Rosen, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 1, 1992
C5 deficiency in A/J mice is not associated with resistance to the development of secondary amyloidosisM Coutinho, K Zahedi, A S Whitehead, et al.
Biochemistry|November 13, 1979
Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequenceA E Davis, C Zalut, F S Rosen, et al.
Pageof 19